Biotechnology - Asia-Pacific, Biotechnology

Filter

Current filters:

Asia-PacificBiotechnology

Popular Filters

1 to 25 of 173 results

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing deal

23-04-2014

US drug major Bristol-Myers Squibb and South Korea’s Samsung BioLogics revealed that they will increase…

Asia-PacificBiotechnologyBristol-Myers SquibbProductionSamsung BioLogics

AusBiotech to submit to Senate’s Australian innovation system inquiry

22-04-2014

Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…

Asia-PacificAustraliaBiotechnologyFinancialResearch

First Asian approval for ophthalmic drug Jetrea, in Malaysia

18-04-2014

Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia…

AlconAsia-PacificBiotechnologyJetreaMalaysiaNovartisOphthalmicsRegulationThromboGenics

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

08-04-2014

US biotech firm Seattle Genetics says it will receive milestone payments from Japan’s Takeda Pharmaceutical…

AdcetrisAsia-PacificBiotechnologyFinancialMarkets & MarketingOncologySeattle GeneticsSouth AmericaTakeda Pharmaceuticals

New funding program to support Australian biopharmaceutical manufacturing development

04-04-2014

The first round of a new pilot funding program opens this week in Queensland, Australia, with at least…

Asia-PacificAustraliaBiotechnologyDSM Biologics

Fast growth forecast for South Korean pharma market

Fast growth forecast for South Korean pharma market

02-04-2014

South Korea's pharmaceuticals market was valued at $20 billion in 2012, growing from $14.5 billion in…

Asia-PacificBiosimilarsBiotechnologyMarkets & MarketingPricingResearch

Australian government plans no action on Pharmaceutical Patent Review

Australian government plans no action on Pharmaceutical Patent Review

27-03-2014

The Australian federal government last week released a statement on the Pharmaceutical Patent Review…

Asia-PacificAustraliaBiotechnologyPatentsResearch

Australian regulator finds no definite melanoma link for natalizumab

Australian regulator finds no definite melanoma link for natalizumab

18-03-2014

Australia’s Therapeutic Goods Administration revealed today that it is monitoring reports of melanoma…

Asia-PacificAustraliaBiogen IdecBiotechnologyNatalizumabNeurologicalRegulationTysabri

Taiwan’s TaiGen Biotech receives domestic marketing approval for Taigexyn

13-03-2014

Taiwan-based drug developer TaiGen Biotechnology says that the Taiwan Food and Drug Administration has…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyRegulationTaiGen BiotechTaigexyn

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech

11-03-2014

Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…

Asia-PacificAustraliaBiotechnologyChinaManagementResearch

Asia-Pacific region sees boom in Biotech investment

Asia-Pacific region sees boom in Biotech investment

07-03-2014

The Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity (PE)…

Asia-PacificBiotechnologyFinancialPatents

AusBiotech continues its call for further tax reform in Australia

AusBiotech continues its call for further tax reform in Australia

04-03-2014

Building on the strategic plan that was presented at AusBiotech national conference last November by…

Asia-PacificAustraliaBiotechnologyFinancialResearch

China set to overtake USA bioscience market

26-02-2014

Bioscience research in China is set to overtake the USA within the next five to ten years, data from…

Asia-PacificBiotechnologyChinaFinancialJapanResearchUSA

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

UCB and Biogen sign Asian license agreement for MS drugs

UCB and Biogen sign Asian license agreement for MS drugs

30-01-2014

Belgian drugmaker UCB and US biotech firm Biogen Idec have signed exclusive agreements granting UCB the…

AlprolixAsia-PacificBiogen IdecBiotechnologyEloctateLicensingNeurologicalPharmaceuticalTecfideraUCB

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story

Genesis 2013: Astex Pharma’s journey from biotech start-up to $886m success story

16-12-2013

A biotech company’s dream 14-year journey from small start-up to an $886 million takeover bid provided…

Asia-PacificAstex PharmaceuticalsBiotechnologyFinancialInterviewsMergers & AcquisitionsOtsukaUKUSA

I-MAK challenges Gilead sofosbuvir patent in India

I-MAK challenges Gilead sofosbuvir patent in India

25-11-2013

USA-based advocacy group the Initiative for Medicines, Access & Knowledge last week filed a challenge…

Anti-viralsAsia-PacificBiotechnologyGilead SciencesPatentssofosbuvirSovaldi

Drug approvals for Bayer in USA and Japan

Drug approvals for Bayer in USA and Japan

23-11-2013

There were two pieces of good news for German Pharma and chemicals major Bayer on Friday (November 22),…

AmgenAsia-PacificBayerBiotechnologyEyleaNexavarNorth AmericaOncologyOnyx PharmaceuticalsOphthalmicsPharmaceuticalRegeneronRegulation

New legislation for regenerative medicine in Japan

New legislation for regenerative medicine in Japan

22-11-2013

The Japanese legislature (Diet) has approved new legislation targeted at regenerative medicine therapies.…

Asia-PacificBiotechnologyCytori TherapeuticsLegalRegulationResearch

Quarterly payments of Australian R&D Tax incentive stalled in review

Quarterly payments of Australian R&D Tax incentive stalled in review

19-11-2013

Trade group AusBiotech has urged Australia’s Coalition Government to deliver on its pro-business rhetoric…

Asia-PacificBiotechnologyFinancialResearch

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

13-11-2013

Merck Serono has signed a global licensing, co-development and commercialization agreement for BeiGene-290…

Asia-PacificBeiGeneBiotechnologyChinaLicensingMerck SeronoOncology

AusBiotech signs MOU with KoreaBIO

08-11-2013

The AusBiotech 2013 national conference culminated last week in the signing of a memorandum of understanding…

Asia-PacificBiotechnologyFinancialPolitics

1 to 25 of 173 results

Back to top